p35 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, but did not affect a cell apoptosis marker as detected by WB. by Ya-Li Zheng (454837)

“…C. p35 siRNA reduced Cdk5 activity. D. Western blotting analysis showed a decline of WT1 expression in p35 siRNA podocytes (upper panel, lane 2 compared to lane 1, p = 0,048), but did not affect cleaved caspase 3 expression (middle panel, lane 2 compare with lane 1). …”

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

Subjects:

Expression levels of OsFdC2 in NIP, <i>hdy1</i> and transgenic lines. by Juan Zhao (109151)

Subjects:

Fibγ^Δ5 mice display decreased survival following <i>S. aureus</i> peritonitis. by Oscar Negrón (11965511)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Decreased responsivity to mechanical stimuli during DRN 5-HT neurons photostimulation. by Guillaume P. Dugué (620333)

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients by J.F.M. Marchini (6515189)

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

Inhibition of PKC or Rho protein kinase decreases Ad5 wild type replication <i>in vitro</i>. by Alice Liu (4814415)

MAP-map analysis of activity decreases within olfactory bulb and preoptic dopaminergic regions. by Jessica C. Nelson (10906236)

Decreased natTregs observed in the lungs in the absence of TLR2. by Amanda McBride (421742)

Loss of Cntnap2 decreases specifically stabilization of new spines. by Amos Gdalyahu (3213810)

“…<b>Left plots</b> analysis per mouse (n = 10 Cntnap2-/- mice, n = 8 WT mice). <b>Right plots</b> analysis per cell (n = 23 Cntnap2-/- neurons, n = 18 WT neurons). …”

Increased body weight and decreased expansion of pro-inflammatory CD4+ T-cells from blood in Tg-HD5 rats. by Osiris Marroquin Belaunzaran (224031)

G0S2 stability is decreased in mice lacking ATGL. by Bradlee L. Heckmann (2818306)

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

MyD88^-/- mice have decreased levels of cytokines in the conjunctiva. by Rose Y. Reins (2586106)

TSLPR deficient mice show decreased AHR upon HDM exposure. by Latifa Koussih (326043)

Forbush Decrease Catalog at MESSENGER by Emma Davies (12046748)

“…Finally, the number of steps observed (1, 2, or C for complex), the quality rating (1--4, from highest to lowest) and the ratio between the 1st and 2nd slope (if present) are given.…”